Sanofi | SNY - Debt



Sanofi reported 22.28B in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
AbbVie USD 69.89B 2.74B Mar/2025
Amgen USD 56.2B 1.18B Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Canopy Growth CAD 327.8M 161.87M Jun/2025
Corcept Therapeutics USD 6.6M 6.6M Jun/2025
Drreddys Laboratories INR 48.64B 2.44B Jun/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Galapagos EUR 10.86M 864K Mar/2025
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Glaxosmithkline GBP 17.35B 368M Jun/2025
J&J USD 52.25B 15.62B Mar/2025
Merck USD 34.84B 2.27B Mar/2025
Novartis USD 31.27B 12M Mar/2025
Novartis USD 32.64B 1.38B Jun/2025
Pacira USD 580.49M 2.88M Jun/2025
Perrigo USD 3.65B 24.4M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
Prestige Brands USD 1.04B 27.25M Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Sanofi 22.28B 1.24B Jun/2025
Sanofi 22.28B 4.38B Jun/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
UCB EUR 3.03B 12M Dec/2024
Zoetis USD 6.79B 214M Jun/2025